Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine vs Chlorthalidone for Hypertension in Liver Transplant Recipients
NCT05275907Phase 4Withdrawn
- Sponsor
- Northwestern University
- Start
- Jul 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorthalidone in hypertension (HTN), sponsored by Northwestern University. Planned start Jul 2022; status: withdrawn.
02
Drugs
chlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05275907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05275907.